Katka Franke

954 citations
9 papers · 233 indexed · h-index 7
Topics
Phagocytosis and Immune Regulation (3 papers)Immune cells in cancer (3 papers)Immune Response and Inflammation (2 papers)

In The Last Decade

Katka Franke

9 papers receiving 226 citations

Peers

Katka Franke
Comparison fields: 5 of 35
  • Immunology 175
  • Molecular Biology 70
  • Radiology, Nuclear Medicine and Imaging 66
  • Oncology 57
  • Physiology 21
Replace Shin Ebihara with:
Shin Ebihara Japan
Courtney A. Iberg United States
Fernanda Castro United Kingdom
Jim West
Hilma J. van der Horst Netherlands
Ekta Patel United States
Siska Wijngaarden Netherlands
Heather Torrey United States
Xiao-Tao Yao United States
Simone Reinwald Australia
Katka Franke relative to Shin Ebihara Japan Shin Ebihara's profile →
Citations per field
00.5×4.5×
Shin Ebihara · 1×
Citations per year

Countries citing papers authored by Katka Franke

Since Specialization
Citations

This map shows the geographic impact of Katka Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katka Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katka Franke more than expected).

Fields of papers citing papers by Katka Franke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katka Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katka Franke. The network helps show where Katka Franke may publish in the future.

Co-authorship network of co-authors of Katka Franke

This figure shows the co-authorship network connecting the top 25 collaborators of Katka Franke. A scholar is included among the top collaborators of Katka Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katka Franke. Katka Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 6
2 15
3 11
4 21
5 18
6 8
7 72
8 81
9
[Level of immunoglobulins A, G and M in the postoperative period].
1

About Katka Franke

Katka Franke is a scholar working on Immunology, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 233 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (3 papers), Immune cells in cancer (3 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (175 citations), Radiology, Nuclear Medicine and Imaging (66 citations) and Oncology (57 citations). Katka Franke has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Hanke L. Matlung, Timo K. van den Berg, Taco W. Kuijpers, Paul J.J.H. Verkuijlen, Michel van Houdt, Thomas Valerius, Louise W. Treffers, Robin van Bruggen, Karin Schornagel and Jan M. Prins. Their work appears in journals such as Frontiers in Immunology, Cancers and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026